Clinical Trial Update: Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for BBIL's ROTAVAC vaccines in Zambia; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Rotavirus Infection

Drugs mentioned

• ROTAVAC 5CM (ROTAVAC 5CM)
• Rotavac

Snippet

Sponsor: Centre for Infectious Disease Research in Zambia | Conditions: Diarrhea, Diarrhea Rotavirus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-12-19